BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24907077)

  • 1. Diabetes mellitus is not a risk factor for coronary artery spasm as assessed by an intracoronary acetylcholine provocation test: angiographic and clinical characteristics of 986 patients.
    Li YJ; Hyun MH; Rha SW; Chen KY; Jin Z; Dang Q; Park CM; Lee JE; Park JY; Choi CU; Na JO; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    J Invasive Cardiol; 2014 Jun; 26(6):234-9. PubMed ID: 24907077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral arterial disease is associated with coronary artery spasm as assessed by an intracoronary acetylcholine provocation test.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Li GP; Saito S; Park JH; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):e78-82. PubMed ID: 19671066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
    Sohn SM; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
    Atherosclerosis; 2018 Jan; 268():163-169. PubMed ID: 29227870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Saito S; Park JH; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    J Hum Hypertens; 2010 Feb; 24(2):77-85. PubMed ID: 19458625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Insulin Resistance on Acetylcholine-Induced Coronary Artery Spasm in Non-Diabetic Patients.
    Kang KW; Choi BG; Rha SW
    Yonsei Med J; 2018 Nov; 59(9):1057-1063. PubMed ID: 30328320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
    Lee EM; Choi MH; Seo HS; Kim HK; Kim NH; Choi CU; Kim JW; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    Atherosclerosis; 2017 Feb; 257():195-200. PubMed ID: 28012648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Arch Cardiovasc Dis; 2018 Mar; 111(3):144-154. PubMed ID: 29030064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis.
    Nam P; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
    Atherosclerosis; 2018 Mar; 270():8-12. PubMed ID: 29407892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of chronic air pollutants with coronary artery spasm, vasospastic angina, and endothelial dysfunction.
    Choi BG; Lee J; Kim SW; Lee MW; Baek MJ; Ryu YG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ; Rha SW
    Coron Artery Dis; 2018 Jun; 29(4):336-343. PubMed ID: 29334505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients.
    Park JY; Rha SW; Poddar KL; Ramasamy S; Chen KY; Li YJ; Choi BG; Ryu SK; Choi JW; Park SH; Park S; Elnagar A; Im SI; Kim SW; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Han SW; Park CG; Seo HS; Oh DJ
    J Cardiol; 2012 Sep; 60(3):187-91. PubMed ID: 22770476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis.
    Choi BG; Park SH; Rha SW; Ahn J; Choi SY; Byun JK; Li H; Mashaly A; Shim MS; Kang JH; Kim W; Choi JY; Park EJ; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2017 Jul; 238():66-71. PubMed ID: 28457560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.
    Sato K; Kaikita K; Nakayama N; Horio E; Yoshimura H; Ono T; Ohba K; Tsujita K; Kojima S; Tayama S; Hokimoto S; Matsui K; Sugiyama S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2013 Jul; 2(4):e000227. PubMed ID: 23858100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
    Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
    Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2018 Aug; 33(8):846-852. PubMed ID: 29435640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year clinical outcomes in patients with significant coronary artery spasm: A propensity score-matched analysis.
    Choi BG; Park SH; Rha SW; Park JY; Choi SY; Park Y; Xu S; Ngow HA; Ali J; Li H; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2015 Apr; 184():533-539. PubMed ID: 25767010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Difference in Coronary Artery Spasm Tested by Intracoronary Acetylcholine Provocation Test in Patients with Nonobstructive Coronary Artery Disease.
    Park JY; Choi SY; Rha SW; Choi BG; Noh YK; Kim YH
    J Interv Cardiol; 2022; 2022():5289776. PubMed ID: 36131847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.